Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Combined chemotherapy and surgery in primary small cell carcinoma of the esophagus.
[esophageal carcinoma]
The
study
was
to
retrospectively
analyze
survival
outcomes
of
surgery
combined
with
chemotherapy
in
primary
small
cell
carcinoma
of
esophagus
.
From
January
2000
to
December
2009
,
all
patients
with
esophageal
carcinoma
and
underwent
esophagectomy
were
selected
from
the
Department
of
Thoracic
Surgery
,
Henan
Cancer
Hospital
,
China
.
They
were
performed
trans--left
thoracic
incision
esophagectomy
.
For
tumor
located
in
the
upper
third
thoracic
esophagus
,
trans--
right
thoracic
incision
and
abdomen
incision
esophagectomy
was
selected
.
We
chose
EP
regimen
for
chemotherapy
.
Results
:
The
percentage
of
pure
esophagus
small
cell
carcinoma
(
57
cases
)
in
all
patients
underwent
esophagectomy
was
1
.
1
%
.
The
median
survival
time
was
45
months
.
In
stage
I
,
II
,
III
,
the
survival
rate
was
25
%
,
5
.
9
%
,
4
.
3
%
respectively
.
In
the
subgroup
analysis
,
overall
median
survival
time
of
surgery
was
23
.
2
months
while
the
time
of
combined
surgery
and
chemotherapy
was
60
.
7
months
(
P
<
0
.
01
)
.
For
stage
I
patients
,
combined
therapy
was
associated
with
a
significant
longer
median
survival
time
(
81
.
9
months
)
than
surgery
alone
(
22
.
3
months
)
.
(
P
<
0
.
01
)
.
Systemic
chemotherapy
of
cisplatin--based
regimens
should
be
considered
as
important
treatment
options
to
improve
survival
outcome
,
even
early
small
cell
esophageal
cancer
.
Diseases
Validation
Diseases presenting
"underwent esophagectomy were selected from the department of thoracic surgery"
symptom
esophageal carcinoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom